Life Science ecosystem in Milan: meeting with Swiss delegation
The Centre for Innovation and Technology Transfer (CITT) at Human Technopole and the Swiss diplomatic representation in Italy, in collaboration with YES MILANO, organised a day-long meeting between Swiss and Italian players working in the field of life sciences. The initiative followed a study tour that CITT experienced in Switzerland in June 2022 to get to know partners in the Swiss innovation ecosystem and pave the way for future collaborations and sharing of best practices on the topic of technology transfer.
The meeting, hosted at the Human Technopole headquarters within MIND – Milano Innovation District, allowed the various entities involved to initiate new relationships and strengthen existing ones.
The programme for the day included a presentation of the Milan life sciences ecosystem, coordinated by Piergiorgio Borgogelli of YES MILANO and involving: Margherita Chierici (TTO IRCCS Ca’ Granda Ospedale Maggiore Policlinico), Daniela Bellomo (Business Development Director San Raffaele), Stefano Minini (Director Lendlease), Felice Lopane (Life Sciences Assolombarda Coordinator), Francesco Cerruti (General Manager Italian Tech Alliance), Paola Testori Coggi (Ambassador Federated Innovation MIND). In the second part of the programme, the Swiss delegation had the opportunity to introduce themselves to the Italian delegates in a pitching session followed by bilateral meetings.
Attached is a copy of the program.
Share:
You could also like:
-
Colorectal Cancer: ML Enhances Cetuximab Response Predictions
An international collaborative study led by Human Technopole, Candiolo Cancer Institute IRCCS in Turin, the University of Turin, and the Wellcome Sanger Institute in Cambridge (UK) has identified new factors associated with therapeutic response in colorectal cancer. The research has led to the development of a machine-learning model capable of accurately predicting the effects of cetuximab, a drug in clinical use, on different colorectal tumour subtypes. Funded by the AIRC Foundation, the study paves the way to identifying molecular features that could serve as biomarkers for predicting treatment response in patients with this type of cancer.
-
Human Technopole Foundation’s Supplier List online
The Human Technopole Foundation’s Supplier Register is now online.
-
HT Director Zerial Awarded Mercurio Prize for Excellence in Research
The Human Technopole Director, Marino Zerial, has been awarded the 2024 Mercurio Prize in the “Research and Development” category, in recognition of the excellence of his research in the field of cell biology. Zerial, renowned for his studies on the mechanisms of endocytosis and cellular transport, has made significant contributions to the understanding of cellular dynamics, with potential therapeutic applications for diseases such as liver conditions.
-
A new model system for cortical development in vitro
Researchers from Human Technopole, the Institute of Molecular Biotechnology and Bicocca University established a method for developing brain assembloids that allows reproducing salient aspects of the antero-posterior polarity of the human cerebral cortex in vitro and opens new possibilities for disease modelling. The study is published in Nature Methods.
-
The National Facility for Genomics with Clelia Peano
Meet Clelia Peano, Head of the National Facility for Genomics. The Facility offers cutting-edge services to develop robust experimental and analytical workflows to explore different genomic research areas, including DNA and RNA analysis, chromatin structure, and epigenetic mechanisms regulating transcription. The goal is to enhance genomic research in all its aspects, benefiting the entire Italian scientific community.